India is being hit by a wave of steel from producers in Japan and South Korea, a government document showed, as mills there redirect supply after US President Donald Trump slapped an import duty on the alloy.

Freight rates decline on restricted cargo Aug 16 2018

Delhi to Kanpur, Baroda and Patna freight rates came down by Rs 1,000 each to Rs 20,000, Rs 24,000 and Rs 28,000.

Rupee jitters bring double whammy for steel sector Aug 16 2018

The rupee slumped 43 paise against the US dollar to trade at a life-time low of 70.32 on strong demand for the American currency.

Home improvement retailer Kingfisher enjoys warm weather boost Aug 16 2018

Kingfisher (KGF.L), Europe’s second largest home improvement retailer, reported a pick-up in underlying sales in its latest quarter, with demand for seasonal products boosted by the prolonged spell of warm weather.

Carlsberg sales boosted by World Cup, raises 2018 outlook Aug 16 2018

Danish brewer Carlsberg (CARLb.CO) raised its full year profit outlook on Thursday after second-quarter sales beat forecasts on growing demand for its expensive beers in China and strong sales in Russia during the World Cup.

Royal London says first half operating profit up one percent Aug 16 2018

Royal London, Britain’s largest mutual life, pensions and investment company, on Thursday posted a 1 percent increase in operating profit, as demand for personal pensions helped offset a dip in group pension sales.

UK regulator sticks to 14 pounds a share floor for Sky from Disney Aug 16 2018

Britain’s Takeover Panel said on Thursday it had confirmed its ruling that Walt Disney (DIS.N) might have to offer at least 14 pounds a share to buy UK pay-television group Sky (SKYB.L).

Starboard buys 5.8 percent stake in Symantec, seeks 5 board seats: WSJ Aug 16 2018

Activist investor Starboard Value LP has taken a 5.8 percent stake in Symantec Corp (SYMC.O) and is seeking five board seats at the cyber-security company, The Wall Street Journal reported.

Pfizer bets on biotech flu vaccine in $425 million BioNTech alliance Aug 16 2018

Pfizer has agreed to pay German biotech firm BioNTech up to $425 million in an alliance to develop more effective influenza jabs, the latest among several major pharma companies to bank on a promising new genetic approach.